Windlas Biotech IPO share allotment likely to be finalised on August 11
Windlas Biotech, one the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization industry in terms of revenue, is expected to finalise the share allotment on August 11, after closing the initial public…
